Key Points
- Insider purchase: Director Tony Young bought 14,233 shares on April 15 at an average price of GBX 140, for a total cost of £19,926.20.
- Stock snapshot: Ct Healthcare Trust (LON:CTHT) opened at GBX 140.20, has a market cap of £78.96 million, a trailing PE of -5.07, and a 52‑week range of GBX 122.43–142.
- Business focus: CT Healthcare Trust is a UK‑listed investment trust concentrating on healthcare and life‑sciences equities to deliver long‑term capital growth through a diversified portfolio.
Ct Healthcare Trust (red) (LON:CTHT - Get Free Report) insider Tony Young acquired 14,233 shares of the firm's stock in a transaction on Wednesday, April 15th. The shares were bought at an average cost of GBX 140 per share, with a total value of £19,926.20.
Ct Healthcare Trust (red) Price Performance
Shares of Ct Healthcare Trust (red) stock opened at GBX 140.20 on Friday. The company has a market capitalization of £78.96 million and a PE ratio of -5.07. Ct Healthcare Trust has a 52 week low of GBX 122.43 and a 52 week high of GBX 142.
Ct Healthcare Trust (red) Company Profile
(
Get Free Report)
CT Healthcare Trust plc (LON: CTHT) is a United Kingdom–listed investment trust that concentrates on the healthcare and life sciences sectors. The company's principal activity is investing in quoted healthcare equities and related instruments with the objective of delivering long‑term capital growth for its shareholders through exposure to companies involved in pharmaceuticals, biotechnology, medical devices, diagnostics and healthcare services.
The trust builds a diversified portfolio across a range of healthcare sub‑sectors and geographies, typically taking positions in established and emerging companies that the board and investment manager consider to have attractive growth prospects, innovative technologies or strong market positions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
